NCT03525080View on ClinicalTrials.gov

Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Brain NeoplasmsAdult Brain Tumor
Interventions
DIAGNOSTIC_TEST

PET imagery

Every patients will have a PET imagery in addition to standard MRI

Trial Locations (1)

35042

Centre Eugène Marquis, Rennes

All Listed Sponsors
lead

Center Eugene Marquis

OTHER

NCT03525080 - Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors | Biotech Hunter | Biotech Hunter